EMEA-000045-PIP01-07
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/3/2008
|
| PIP number |
EMEA-000045-PIP01-07
|
| Pharmaceutical form(s) |
Tablet
|
| Condition(s) / indication(s) |
Risk of myocardial infarction, stroke, death from cardiovascular causes, or hospitalization forcongestive heart failure in patients at high risk of developing major cardiovascular events
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Boehringer Ingelheim International GmbH
Tel. +49 6132 778271 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|